Categories: News

TRxADE Group, Inc. Announces Name Change to TRxADE HEALTH, INC.

TAMPA, FL / ACCESSWIRE / May 28, 2021 / TRxADE Group, Inc. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that the Company will be changing its name to TRxADE HEALTH, Inc., effective Tuesday, June 1, 2021, to reflect its new mission and strategic direction of the business.

The name change does not affect the rights of the Company’s stockholders, creditors, customers or suppliers. The Company’s common stock will continue to trade on the NASDAQ Capital Market under the current trading symbol “MEDS“. The Company’s current stockholders will not need to exchange their current stock certificates as the stock certificates reflecting the Company’s prior corporate name will continue to be valid. The name change is expected to be effective on The Nasdaq Capital Market on Tuesday, June 1, 2021.

“In 2020, we formed several companies focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. We believe the name “TRxADE HEALTH, INC.” will better describe the changed focus of the Company, to a health services IT company focused on digitalizing the retail pharmacy experience,” said Suren Ajjarapu, Chief Executive Officer of the Company.

About TRxADE Group, Inc.

TRxADE Group (NASDAQ: MEDS) is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The Company operates the TRxADE drug procurement marketplace serving a total of 12,100+ members nationwide, fostering price transparency and under the Bonum Health brand, offering patient centric telehealth services. For more information on TRxADE Group, please visit the Company’s IR website at investors.trxadegroup.com.

Investor Relations:

Lucas Zimmerman
Senior Vice President
MZ Group – MZ North America
(949) 259-4987
MEDS@mzgroup.us
www.mzgroup.us

SOURCE: Trxade Group, Inc.

View source version on accesswire.com:
https://www.accesswire.com/649589/TRxADE-Group-Inc-Announces-Name-Change-to-TRxADE-HEALTH-INC

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

5 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

8 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

8 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

8 hours ago